Abstract Low-income African-American women report elevated prenatal depressive symptoms more often (42 %) than the national average (20 %). In the USA in 2012, 16.5 % of African-American women experienced a premature birth (less than 36 completed gestational weeks) compared to 10.3 % of white women. In addition, 13 % of African-American women had a low-birth weight infant (less than 2,500 g) compared to 7 % of white women. Variation in the neuropeptide, oxytocin has been implicated in perinatal depression, maternal behavior, regulation of stress responses, and may be associated with this health disparity. The purpose of this investigation was to examine factors associated with prenatal depressive symptoms, including plasma oxytocin levels and birth weight, in a sample of urban African-American women. Pregnant African-American women (N=57) completed surveys and had blood drawn twice during pregnancy at 15-22 weeks and 25-37 weeks. In addition, birth data were collected from medical records. A large number of participants reported elevated prenatal depressive symptoms at the first (n=20, 35 %) and the second (n=19, 33 %) data points. Depressive symptoms were higher in multigravidas (t(51)=−2.374, p= 0.02), women with higher anxiety (r(47)=0.71, p=0.001), women who delivered their infants at an earlier gestational age (r(51)=−0.285, p=0.04), and those without the support of the infant's father (F(4, 48)=2.676, p=0.04). Depressive symptoms were also higher in women with low oxytocin levels than in women with high oxytocin levels (F(2, 47)= 3.3, p=0.05). In addition, women who had low oxytocin tended to have infants with lower birth weights (F(2, 47)= 2.9, p=0.06). Neither prenatal depressive symptoms nor prenatal oxytocin levels were associated with premature birth. Pregnant multigravida African-American women with increased levels of anxiety and lacking the baby's father's support during the pregnancy are at higher risk for prenatal depressive symptoms. Prenatal depressive symptoms are associated with low oxytocin levels and lower infant birth weights. Further research is needed to understand the mechanisms between prenatal depressive symptoms, oxytocin, and birth weight in order to better understand this health disparity.
overall health, low education, history of depression (Marcus et al. 2003) , history of childhood sexual abuse (Rodgers et al. 2003) , lower levels of support (Myers et al. 2013) , and elevated levels of anxiety (Field et al. 2003) . Neonates whose mothers have elevated prenatal depressive symptoms are at risk for neurobehavioral dysregulation as reflected by less positive affect, lower vagal tone, and elevated cortisol levels (Field et al. 2006) . Prenatal depressive symptoms contribute to altered patterns of mother-infant relationships, such as the mother's expressed lack of desire for close contact with her infant, lack of satisfaction with being a mother, hostility, and feelings of resentment toward her infant (Perry et al. 2011) .
The biological mechanisms underlying this health disparity in pregnant African-American women are poorly understood. In order to identify women at risk for prenatal depression, providers screen pregnant women using interview techniques or validated screening questionnaires (Boyd et al. 2005) . The American College of Obstetrics and Gynecology, however, does not recommend universal screening of pregnant or postpartum women for depression but recommends screening per the providers' discretion and preference (American College of Obstetricians and Gynecologists 2010). Understanding the biological pathway for prenatal depression in AfricanAmerican women may increase the capacity for identification of women at risk before symptoms are present. Understanding this biological pathway may also enhance opportunities for providing needed treatment of vulnerable mothers, thus improving infant outcomes. Previous reports have suggested oxytocin may be part of the potential biological pathways involved in perinatal depression (Feldman et al. , 2012 Gimpl and Fahrenholz 2001; Gordon et al. 2010; Gouin et al. 2010; Levine et al. 2007; Ozsoy et al. 2009; Scantamburlo et al. 2007; Skrundz et al. 2011) . Accordingly, we hypothesized that oxytocin levels may predict perinatal depression.
Oxytocin is a nonapeptide hormone primarily synthesized in the brain, but also synthesized in the peripheral organs (uterus, placenta, amnion, corpus luteum, testis, and heart). Oxytocin is released in response to various stimuli including social interactions, vaginal stimulation, labor progression, and lactation (Gimpl and Fahrenholz 2001 Pedersen et al. 1982; Heinrichs and Domes 2008) . Low levels of oxytocin have been linked to altered patterns of mother-infant interactions including less touch (Feldman et al. 2012) , whereas high levels of oxytocin have been associated with greater mother-newborn interactions including increased gaze, vocalization, positive affect, and touch Levine et al. 2007 ). Finally, low oxytocin levels in pregnancy may be predictive of postpartum depressive symptoms (Skrundz et al. 2011 ). However, oxytocin has not been explored during pregnancy in an urban African-American sample. In a sample of urban AfricanAmerican women, we examined factors potentially associated with prenatal depressive symptoms including plasma oxytocin levels, birth weight/prematurity, demographics, anxiety, support from the infant's father, and maternal health history.
Materials and method

Design
The data for this secondary analysis were obtained from a larger longitudinal study of pregnant African-American women. The larger study was designed to examine stress, pregnancy, and birth outcomes. Data were collected twice during pregnancy (15-22 and 25-37 weeks) . Birth data were obtained from medical records.
Setting
Participants were recruited from a large medical center in Chicago, Illinois. Women were recruited after their standard prenatal care appointment.
Subjects
Subjects included 57 pregnant African-American women at a prenatal care appointment between 15-and 22-week gestation. Women were invited into the study if they were 18 years of age or older, had a singleton pregnancy, and were able to read and write English. Per the larger longitudinal study, subjects with hypertension, pregestational diabetes, human immunodeficiency virus (HIV), autoimmune disorders, a multiple gestation pregnancy, or receiving medications such as dexamethasone, betamethasone, or inhaled steroid were excluded from the study. These characteristics may affect the larger study outcomes of maternal stress and pregnancy.
Measures
Data collected included medical record review for birth outcomes (e.g., gestational age at birth and birth weight), blood samples for plasma oxytocin analysis, and self-reported questionnaires.
Plasma oxytocin was analyzed in duplicate using enzymelinked immunoassay (ELISA) (Enzo Life Sciences). Oxytocin detection levels were 15.6 pg/ml to 1,000 pg/ml (AssayDesigns 2006). The intra-assay coefficient of variability was 9.7 to 30 %, and an inter-assay coefficient of variability was 4.6 to 8.6 %.
Self-reported data included a sociodemographic questionnaire in which women indicated their age, marital status, education, household income, and family involvement that included support of the infant's father during pregnancy. Additionally, participants completed previously validated instruments to assess state anxiety and prenatal depressive symptoms.
State anxiety was measured by the State-Trait Anxiety Inventory (STAI) (Spielberger 1983) . The state subscale of the STAI consists of 20 items (e.g., feeling happy, calm, jittery, upset, confused) rated on a 4-point Likert scale (1=not at all and 4=very much so) with scores ranging from 20-80. A higher score is associated with higher levels of anxiety (Spielberger 1983) . The Cronbach's alpha for this study was 0.91.
Prenatal depressive symptoms were measured using the Center for Epidemiologic Studies Depression Scale (CESD) (Canady et al. 2009; Radloff 1977a) . The CESD consists of 20 depressive symptoms (e.g., lonely, sad, restless) rated on a 4-point Likert scale (0=rarely or none of the time to 3=most or all of the time) with scores ranging from 0-60. A score of 16 or greater indicates clinically elevated depressive symptoms (Radloff 1977b) . For this study, the Cronbach's alpha was 0.84.
Procedures
The Institutional Review Board at the University of Illinois at Chicago approved this study. Pregnant African-American women between 15-and 22-week gestation were invited to participate. After giving informed consent, participants completed the packet of questionnaires in a private room after their prenatal visit. No stimuli were present that may affect oxytocin levels (such as pictures of loved ones, baby toys/dolls, or pregnancy/baby-related magazines). On the same day, the participant's blood was drawn into an ethylenediaminetetracetic acid (EDTA) sterile tube (10 ml) and placed on ice. This was completed in the afternoon (1:00 p.m.-5:00 p.m.) for consistency. The samples were transported on ice, centrifuged (1,500×g, 15 min), and aliquoted within 3 h of withdrawal. Once plasma was aliquoted, the samples were stored at −80°C for batch analysis. All assays were conducted according to manufacturer specifications, but samples were not extracted. Participants were given a US$25 gift card for their participation and time. Three participants did not return to the clinic between 25 and 37 weeks, and two additional participants delivered prior to the second data collection time. A member of the research team completed a maternal medical record review prenatally and postpartum (for birth data). The participants were not contacted after birth.
Data analysis
Descriptive statistics were generated to describe sample characteristics. Paired sample t tests were computed to analyze changes in depressive symptoms and oxytocin between the first and second data collection. Independent t tests were computed to examine the relationship between prenatal depressive symptoms and gravida status (primigravida versus multigravida). Spearman's correlation coefficient was computed to examine the relationships among depressive symptoms, raw oxytocin levels, birth weight, gestational age at birth, and anxiety. Analysis of variance was computed to examine depressive symptoms and support of the infant's father during the pregnancy.
Due to the wide range of oxytocin values previously reported in the literature , after continuous data analysis, raw oxytocin values were categorized as low, normal, and high. These category distinctions were based on previous reports (Gouin et al. 2010 ) and graphical cut points. A one-way analysis of variance (ANOVA) was computed to examine the relationships between oxytocin categories and prenatal depressive symptoms, birth weight, and gestational age at birth.
Results
Sample characteristics
The average age of women in our sample was 23.4 (SD = 4.8) years, and ages ranged between 18 and 36 years. Subjects' predominately delivered their infants at term with an average gestational age at birth of 38.6 (SD = 2.5) weeks, with ranges from 25-41 weeks. The majority of women were multigravidas (75 %). Most subjects did not have a college degree (86 %) and had an annual income less than US$30,000 (85 %). A majority of women (70 %) reported the baby's father was fully involved with the pregnancy. At the first time point, subjects reported moderate levels of anxiety (STAI = 35, SD = 11), and 35 % had elevated depressive symptoms (score ≥16 on CESD). No significant differences were found in state anxiety or depressive symptoms between the first and second time point (see Table 1 ).
The average oxytocin value was 504 pg/ml, SD=284.2, with a range between 170 and 2,056 pg/ml. No significant differences in oxytocin levels were found between the first and second time point. Therefore, we conducted the remaining analysis only with the first data point. Oxytocin data was divided into low (<400 pg/ml), medium (401-700 pg/ml), and high (>701 pg/ml) categories, based on the distribution of the data and corroborated by previous reports on oxytocin (Gouin et al. 2010; Levine et al. 2007; Rubin et al. 2010) . The low category represented the lower 35 %, while the high category represented the upper 10 %. The mean depressive symptoms in the low, normal, and high oxytocin categories were 15.6, 12.4, and 5.3, respectively (see Table 2 ).
Factors associated with prenatal depressive symptoms, oxytocin, and birth weights Depressive symptoms were higher in multigravidas (t (51) = −2.37, p=0.02), women with higher anxiety (r (47) =0.71, p= 0.001), women who delivered their infants at an earlier gestational age (r (51) =−0.29, p=0.04), and those without the support of the infant's father (F (4,48) =2.676, p=0.04). There was no statistical relationship between depressive symptoms and birth weight (r (50) =−0.21, p=0.15) or raw oxytocin levels(r (51) = −0.10, p=0.53). After depressive symptoms were dichotomized into elevated and non-elevated (CESD score ≥16), there continued to be no statistical relationship between elevated depressive symptoms and birth weight (t (48) =1.4, p=0.17) or raw oxytocin levels (t (48) =0.60, p=0.55). In addition, there was no relationship between the group of participants with elevated depressive symptoms (CESD score ≥16) and oxytocin category (low, medium, or high) (X 2 (2, N=50) =3.5, p=0.18). Oxytocin categories (low, medium, or high) and depressive symptoms (CESD scores) were related. Depressive symptoms were higher in women with low levels of oxytocin (n=17) compared to women with high levels of oxytocin (n=5) (F (2, 47) =3.3, p=0.05, Fisher's least significant difference (LSD)= 0.015) (see Fig. 1 ).
In addition, women with low levels of oxytocin also tended to be more likely to have infants with lower birth weights compared to women categorized as having medium and high levels of oxytocin (F (2, 47) =2.9, p=0.06, LSD=0.037, 0.063, respectively), although this difference in birth weights is not clinically significant (see Fig. 2 ). There was no relationship between oxytocin categories (low, medium, or high) and gestational age at birth.
Discussion
In pregnant African-American, primarily low-income women, a large percentage (35 %) experienced elevated prenatal depressive symptoms. Depressive symptoms were higher in multigravidas, women who reported greater anxiety, and in women without involvement from the baby's father. In addition, women with elevated prenatal depressive symptoms more frequently had low levels of prenatal oxytocin and earlier gestational ages at birth.
The prevalence of elevated prenatal depressive symptoms is consistent with other studies of pregnant African-American women (Tandon et al. 2012; Holditch-Davis et al. 2009 ) and low-income mothers (Segre et al. 2007; Chaudron et al. 2010) . Previous reports also identified anxiety and depression as comorbid conditions (Kinsella and Monk 2009 ). In addition, we found the mean anxiety levels in our sample (STAI mean= 34) were similar to other reports from low-income, predominately African-American pregnant women (STAI mean=39) (Zachariah 2009 ). Other researchers have found that women with low levels of social support also reported higher levels of prenatal depressive symptoms (Aktan 2012; Webster et al. 2000) . Specifically, the social support of the infant's father has been identified as a protective factor for elevated postpartum depressive symptoms (Mezulis et al. 2004; Smith and Howard 2008; Fagan and Lee 2010) .
The wide range (170-2,056 pg/ml) of raw oxytocin levels reported in this investigation is consistent with previous studies using a similar methodology Prevost et al. 2014) . The range of possible oxytocin values between our sample and other reports is comparable with oxytocin values in some cases exceeding 2,000 pg/ml. The mean value of oxytocin from our sample was 504 pg/ml, compared to values of approximately 300 pg/ml, which are typical of other populations using identical measures Prevost et al. 2014) . The comparatively high levels of oxytocin measured in this study may reflect physiological coping mechanisms associated with lifestyle in this vulnerable lowincome pregnant African-American population. We identified a relationship between low oxytocin category and increased prenatal depressive symptoms. Prior reports have identified lower prenatal oxytocin values as a risk factor for postpartum depressive symptoms (Skrundz et al. 2011) . In addition, the literature provides support that higher prenatal oxytocin values are related to positive postpartum maternal behaviors such as gaze, affect, touch, and vocalization during the first month postpartum ). Higher postpartum oxytocin levels have been associated with positive affectionate parenting including vocalization, positive affect, and touch (Gordon et al. 2010) . In a non-pregnant population, lower oxytocin has been identified in individuals with greater depressive symptoms (Ozsoy et al. 2009; Scantamburlo et al. 2007 ).
Women with low prenatal oxytocin levels delivered infants who tended to have lower birth weights when compared to mothers with medium and high oxytocin levels. The mean difference in birth weight was not clinically significant, but it raises the question of the potential relationship between these factors.
Study limitations
Limitations of this study include (1) small sample size, (2) limited variables, and (3) inclusion of only African-American women. The sample size of 57 women included 6 women who had a premature birth. Further analysis with premature birth, prenatal depressive symptoms, and oxytocin were limited based on the small number of premature births. Second, because this study was a secondary analysis of existing data, we were limited by its design and the data collected. For example, longitudinal data from the postpartum period may have provided a more complete understanding of the ways The relationship between prenatal oxytocin category and infant birth weight trended toward significance. The relationship between infant birth weight and raw prenatal oxytocin values was not significant. Error bars represent one standard error from the mean. Sample size for the groups is as follows: less than 400, n=17; 401-700, n=27; greater than 701, n=5 these factors are associated. The third limitation is based on the homogeneity of the sample. The urban, low-income, African-American women in our sample may have experienced unique life events affecting their oxytocin levels and their self-report of prenatal depressive symptoms. This sample was chosen due to the known increased risk of prenatal depression in African-American women, yet this limits the generalizability of these results.
Conclusions
A large percentage of pregnant African-American urban women report elevated prenatal depressive symptoms. There are many factors related to elevated prenatal depressive symptoms, and oxytocin may be one of the biological pathways explaining this increased risk. Understanding the biologic pathway of prenatal depressive symptoms may also explain other pregnancy health disparities in African-American women such as premature birth. Identifying the biological pathway for depressive symptoms might allow for improved identification and future treatment. Early identification of pregnant women at risk for depressive symptoms may improve known sequelae such as maternal health, mother-infant interactions, and infant development (Weisman et al. 2010; Beck 2008 ).
